Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation

Head and Neck Cancer

Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma

Cancer Cytopathol.

Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN Jr, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, Ferris RL, Carey TE, Myers JN, Pickering CR; Head and Neck Cancer Specialized Program of Research Excellence (SPORE) Human Immunodeficiency Virus (HIV) Supplement Consortium

doi: 10.1002/cncr.31063.

Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature

BMC Cancer.

Grønhøj C, Jensen DH, Agander T, Kiss K, Høgdall E, Specht L, Bagger FO, Nielsen FC, von Buchwald C

doi: 10.1186/s12885-018-4567-3.

Head and Neck Cancer

Patterns of antibody responses to non-viral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status

Int J Cancer.

Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende C, Dyckhoff G, Boscolo-Rizzo P, Ezic J, Marienfeld RB, Möller P, Völkel G, Kraus JM, Kestler HA, Brunner C, Schuler PJ, Wigand M, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Butt J, Waterboer T, Laban S

doi: 10.1002/ijc.32623.

RECOMMENDED

Head and Neck Cancer

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma

Oncoimmunology.

Lechner A, Schlößer HA, Thelen M, Wennhold K, Rothschild SI, Gilles R, Quaas A, Siefer OG, Huebbers CU, Cukuroglu E, Göke J, Hillmer A, Gathof B, Meyer MF, Klussmann JP, Shimabukuro-Vornhagen A, Theurich S, Beutner D, von Bergwelt-Baildon M

doi: 10.1080/2162402X.

Skin Cancer

Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma

JAMA Dermatol.

Tokez S, Hollestein L, Louwman M, Nijsten T, Wakkee M

doi: 10.1001/jamadermatol.2020.3677.

SPECIAL REPORT

Skin Cancer

Bavencio^® (Avelumab): Treatment for Metastatic Merkel Cell Carcinoma^1,2

RECOMMENDED

Head and Neck Cancer

Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

JAMA Oncol.

Fakhry C, Blackford AL, Neuner G, Xiao W, Jiang B, Agrawal A, Gillison ML

doi: 10.1001/jamaoncol.

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Front Oncol.

Argiris A, Harrington K, Tahara M, Schulten J, Chomette P, Ferreira Castro A, Licitra L

doi: 10.3389/fonc.2017.00072.

Head and Neck Cancer

Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients

Clin Cancer Res.

Laban S, Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende CC, Dyckhoff G, Boscolo-Rizzo P, Ezić J, Marienfeld R, Möller P, Kraus JM, Völkel G, Kestler HA, Brunner C, Schuler PJ, Wigand MC, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Waterboer T, Butt J

doi: 10.1158/1078-0432.CCR-19-1490.

Related content

Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma

Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature

Patterns of antibody responses to non-viral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma

Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma

Bavencio® (Avelumab): Treatment for Metastatic Merkel Cell Carcinoma1,2

Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients

Bavencio^® (Avelumab): Treatment for Metastatic Merkel Cell Carcinoma^1,2